Exicure, Inc.
corporate_fare Company Profile
Exicure, Inc. (NASDAQ:XCUR) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 30 items for XCUR at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for XCUR spans 10-Q, 8-K, PRE 14A, 4.
Recent high-impact activity:
- Exicure Q3: $1.2M Cash, Going Concern, Nasdaq Equity Shortfall Before Dec 2 Deadline
- Exicure Signs Parkinson's Device Deal; Plans 20%-100% NeuroQ Stake Via Share Issuance
- Exicure Delays Q3 10-Q, Citing Accounting Review of Assets and Liabilities
- Exicure to Sell GPC-100 Program to GPCRT for ~US$4.8M Cash
- Exicure to Sell GPC-100 Program to Korea's GPCRT for ~$4.8M Cash
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 52,218 shares in XCUR as of the October 30, 2026 settlement, a 21.7% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 15.6% of XCUR volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.